| |
| |
|
| Insider
Information: |
Ray Debanjan |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,928 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
Chief Financial Officer |
2018-12-12 |
5,928 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-09-01 |
4 |
AS |
$17.17 |
$42,925 |
D/D |
(2,500) |
17,126 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-01 |
4 |
OE |
$1.26 |
$16,379 |
D/D |
13,000 |
17,741 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2018-03-02 |
4 |
OE |
$1.13 |
$23,373 |
D/D |
20,000 |
19,226 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-08-09 |
4 |
AS |
$15.00 |
$37,500 |
D/D |
(2,500) |
19,626 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2017-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,928 |
|
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-07-03 |
4 |
AS |
$15.47 |
$38,675 |
D/D |
(2,500) |
22,126 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2017-05-31 |
4 |
A |
$8.68 |
$23,415 |
D/D |
2,698 |
24,626 |
0 |
- |
|
32 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
